|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Dr._Anand_Anandkumar
|
|
gptkbp:collaboratesWith
|
gptkb:GARDP
gptkb:University_of_Queensland
|
|
gptkbp:focusesOn
|
gptkb:antibiotic
antibiotic drug discovery
|
|
gptkbp:foundedIn
|
2014
|
|
gptkbp:founder
|
gptkb:Dr._Anand_Anandkumar
gptkb:Dr._R._Ananthanarayanan
gptkb:Dr._V._Balasubramanian
|
|
gptkbp:fundedBy
|
gptkb:Global_Antibiotic_Research_and_Development_Partnership
gptkb:CARB-X
gptkb:CCAMP
gptkb:Evonik_Venture_Capital
gptkb:University_of_Tokyo_Edge_Capital
gptkb:University_of_Queensland
gptkb:Acumen_Fund
gptkb:3one4_Capital
|
|
gptkbp:headquartersLocation
|
gptkb:Bangalore
gptkb:India
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bugworks
|
|
gptkbp:industry
|
gptkb:biotechnology
pharmaceuticals
|
|
gptkbp:notableAchievement
|
first Indian company to enter CARB-X portfolio
|
|
gptkbp:notableProject
|
BWC0977
novel broad-spectrum antibiotics
|
|
gptkbp:officeLocation
|
gptkb:Australia
gptkb:United_States
|
|
gptkbp:specializesIn
|
drug discovery for multi-drug resistant bacteria
precision antibiotics
|
|
gptkbp:website
|
https://bugworksresearch.com/
|
|
gptkbp:bfsParent
|
gptkb:Chiratae_Ventures
|
|
gptkbp:bfsLayer
|
6
|